Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)

Abroad (travel likely)Active Not RecruitingPHASE2

Conditions

Non-Small Cell Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Research Site, Duarte, California, United States
Research Site, Los Angeles, California, United States
Research Site, Sacramento, California, United States
Research Site, Santa Monica, California, United States
Research Site, New Haven, Connecticut, United States
Research Site, Chicago, Illinois, United States
Research Site, Baltimore, Maryland, United States
Research Site, Boston, Massachusetts, United States
Research Site, Boston, Massachusetts, United States
Research Site, Grand Rapids, Michigan, United States
Research Site, New York, New York, United States
Research Site, New York, New York, United States
Research Site, Portland, Oregon, United States
Research Site, Pittsburgh, Pennsylvania, United States
Research Site, Houston, Texas, United States
Research Site, Seattle, Washington, United States
Research Site, Odense C, Denmark
Research Site, Catania, Italy
Research Site, Naples, Italy
Research Site, Orbassano, Italy
Research Site, Padova, Italy
Research Site, Varese, Italy
Research Site, Chūōku, Japan
Research Site, Fukuoka, Japan
Research Site, Kōtoku, Japan
Research Site, Nagoya, Japan
Research Site, Osaka, Japan
Research Site, Wakayama, Japan
Research Site, Amsterdam, Netherlands
Research Site, Amsterdam, Netherlands
Research Site, Maastricht, Netherlands
Research Site, Nijmegen, Netherlands
Research Site, Rotterdam, Netherlands
Research Site, Drammen, Norway
Research Site, Oslo, Norway
Research Site, Trondheim, Norway
Research Site, Seongnam-si, South Korea
Research Site, Seoul, South Korea
Research Site, Seoul, South Korea
Research Site, Seoul, South Korea
Research Site, A Coruña, Spain
Research Site, Barcelona, Spain
Research Site, Barcelona, Spain
Research Site, Madrid, Spain
Research Site, Madrid, Spain
Research Site, Seville, Spain
Research Site, Stockholm, Sweden

Study leads

Helena A Yu, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA

View source on ClinicalTrials.gov